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Abstract
Preterm birth affects over 12% of all infants born in the US yet the biology of early delivery
remains unclear, including whether epigenetic mechanisms are involved. We examined
associations of maternal and umbilical cord blood long interspersed nuclear element-1 (LINE-1)
DNA methylation with length of gestation and odds of preterm birth in singleton pregnancies in
Project Viva. In white blood cells from maternal blood during 1st trimester (n=914) and 2nd
trimester (n=922), and from venous cord blood at delivery (n=557), we measured LINE-1 by
pyrosequencing (expressed as %5 methyl cytosines within the LINE-1 region analyzed [%5mC]).
We ran linear regression models to analyze differences in gestation length, and logistic models for
odds of preterm birth (<37 v. ≥37 weeks gestation), across quartiles of LINE-1. Mean(SD) LINE-1
levels were 84.3(0.6), 84.5(0.4), and 84.6(0.7) %5mC for 1st trimester, 2nd trimester and cord
blood, respectively. Mean(SD) gestational age was 39.5(1.8) weeks, and 6.5% of infants were
born preterm. After adjustment for maternal age, race/ethnicity, BMI, education, smoking status,
and fetal sex, women with the highest vs. lowest quartile of 1st trimester LINE-1 had longer
gestations (0.45 weeks [95% CI 0.12, 0.78]) and lower odds of preterm birth (OR 0.40 [0.17,
0.94]), whereas associations with cord blood LINE-1 were in the opposite direction (−0.45 weeks,
−0.83, −0.08) and (OR 4.55 [1.18, 17.5]). In conclusion, higher early pregnancy LINE-1 predicts
lower risk of preterm birth. In contrast, preterm birth is associated with lower LINE-1 in cord
blood.
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INTRODUCTION
Despite much research and healthcare effort, preterm birth remains a major public health
problem. In the United States over 12% of infants are born preterm (<37 weeks’ gestation).1
Preterm birth contributes to over a third of all US infant mortality,2 and is linked to major
long-term morbidities.3, 4 While social determinants such as poverty,5 African-American
race/ethnicity,6 and biologic risk factors such as genital infections7–9 and tobacco
exposure10 affect a woman’s risk of delivering preterm, the mechanisms connecting risk
factors to preterm birth remain unclear.11
Gene-environment interactions may account for much of the variation in risk of delivering
preterm and may work through epigenetic phenomena.12 Epigenetics refers to heritable
differences in gene expression in the absence of genetic sequence variation.13 DNA
methylation of cytosine-guanine (CpG) dinucleotides represents one of several known
epigenetic mechanisms. Typically, in eukaryotic cells, methylation of CpG sites within
promoter regions of genes silences gene expression.14 One option of interrogating DNA
methylation involves analyzing particular genes. Another approach is to analyze DNA
repetitive sequences, 13, 15, 16 since they comprise more than half of the human genome
including over 500,000 heavily methylated long interspersed nucleotide elements
(LINE-1).17 Typically LINE-1 is heavily methylated, but in states of cellular stress,
repetitive elements can be hypomethylated.18, 19
While no human cohort studies report associations between epigenetic marks and the length
of gestation or preterm birth, recent human studies raise the possibility that epigenetics may
underlie differences in risk of preterm birth. While DNA methylation of organ tissues
specifically involved in preterm delivery, including the placenta and fetal tissues, may
provide more information, the DNA methylation of circulating white blood cells has been
associated with other non-hematologic disease processes.20, 21 Blood DNA hypomethylation
of LINE-1 has been associated with cardiovascular disease,21 and with risk factors for both
cardiovascular disease and preterm birth22, 23 including smoking24 and folate
deficiency.23, 25 Cardiovascular disease and preterm delivery may share pathophysiologic
mechanisms as women who have had a prior preterm delivery have been shown to have
higher odds of developing cardiovascular disease.26 Both of these states have been
associated with inflammation, raising the question as to whether LINE-1 hypomethylation
represents an aggregate measure of inflammation over time that could be associated with an
increased risk of preterm birth.
Other epidemiologic observations also suggest a role for epigenetic disruptions and an
increased risk of preterm birth. Large meta-analyses have shown that pregnancies conceived
via in vitro fertilization (IVF) have higher odds of preterm birth compared to non-IVF
conceived pregnancies.27–29 During the process of IVF, manipulation of the cells occurs at a
time when DNA is demethylated and remethylated30 which may be a window of particular
epigenetic susceptibility, supported by studies linking higher risk of imprinting disorders
and IVF.31 Whether epigenetic alterations caused by IVF lead to an increased risk of
preterm birth or whether epigenetic factors contribute both to infertility and subsequent
preterm birth remains unknown. However, the association between IVF and preterm birth
suggests a potential role for epigenetic contributions to preterm birth.
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The aim of this study was to examine the extent to which LINE-1 methylation in maternal
peripheral blood during pregnancy, and in umbilical cord blood, is associated with length of
gestation and risk of preterm birth. Because lower LINE-1 methylation has been associated
with many states of poor health,20, 21, 32, 33 we hypothesized that higher LINE-1 methylation
during pregnancy would be associated with longer gestations and lower odds of preterm
delivery.
METHODS
Study Subjects
We studied participants enrolled in Project Viva, a pre-birth cohort study of mother-infant
pairs recruited from obstetric offices of Harvard Vanguard Medical Associates, a multi-
specialty group practice in eastern Massachusetts.34 Eligibility to participate in the study
included English fluency, singleton pregnancy and gestational age less than 22 weeks at the
time of enrollment. Details of recruitment and retention procedures are published
elsewhere.34, 35 Of the 2128 mothers with live births enrolled in the study, we analyzed data
from the subset of 1160 participants with maternal blood DNA from the first trimester
(n=914), the second trimester (n=922), and/or umbilical cord blood DNA at delivery
(n=577). Not all participants had samples available at each time point. However, there was
substantial overlap; 729 women had both first and second trimester samples available and
for the 557 infants with cord blood samples there were 428 maternal first trimester and 427
maternal second trimester samples. Comparison of the 1160 participants in this analysis 968
excluded participants showed a higher proportion of maternal white race (74% vs. 58%) and
college or graduate education (70% vs. 59%) and a slightly lower proportion of infants born
<37 weeks’ gestation (6% vs. 8%). Mothers provided written, informed consent to
participate in the study and to have their DNA analyzed. The institutional review boards of
the participating institutions, including Harvard Pilgrim Health Care, Brigham and Women’s
Hospital and Beth Israel Deaconess Medical Center, approved the study.
Gestational Age
We calculated gestational age in weeks by subtracting the date of the last menstrual period
from the date of delivery. Eighty-six percent of the mothers had ultrasound data available at
16–20 weeks. For 12% of subjects, ultrasound pregnancy dating estimates differed by more
than 10 days from the LMP, and for them we used the dating obtained from the ultrasound
to determine gestational age at birth. We categorized infants as preterm if the gestational age
at birth was less than 37 completed weeks of gestation.
Covariate Ascertainment
Using a combination of interviews, study questionnaires and medical record reviews, we
collected information on maternal age, self-designated race/ethnicity, parity, smoking habits,
education, marital status, household income, and infant sex. We calculated prepregnancy
body mass index (BMI, kg/m2) based on self-reported prepregnancy height and weight. We
categorized deliveries as “spontaneous” if labor preceded either a vaginal birth or a cesarean
section, or as “medically indicated” if cesarean or induced vaginal birth occurred in the
absence of spontaneous labor.
LINE-1 DNA Methylation Analysis
We collected venous whole blood samples at the end of the first and second trimesters of
pregnancy during in-person study visits and from the umbilical cord at delivery. We
immediately refrigerated samples and transferred them to laboratory. There, they were spun
and blood components were separated into aliquots for storage at −80°C. We extracted high
Burris et al. Page 3
J Dev Orig Health Dis. Author manuscript; available in PMC 2012 June 18.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
molecular weight genomic DNA from the buffy coat with commercially available PureGene
Kits (Gentra Systems, Minneapolis, MN) to prepare the samples for pyrosequencing.
As previously described,21, 36, 37 we quantified DNA methylation using bisulfite-PCR and
pyrosequencing to analyze the methylation at 4 CpG sites repeated throughout the genome.
We used primers designed toward a consensus LINE-1 sequence that repeats with no
variation in the majority of the genomic LINE-1 repeated elements. To verify bisulfite
conversion, we used non-CpG cytosines as built-in controls. We measured methylation as a
percentage of 5-methyl cytosines (%5mC), within the regions as studied, in two replicates
(runs) and combined measures from two runs and four sites as described below. As part of a
pilot, we had previously analyzed a subset (n=48) of the cord blood samples at just 3 CpG
sites.
Statistical Analysis
To estimate LINE-1 methylation we fit a mixed effects model38 to the direct LINE-1
measures at the 4 CpG sites allowing a different mean level at each site in each run, for 8
modeled means all together. For example, site 1 in run 1 had a different modeled mean from
site 2 in run 1 and from site 1 in run 2. This approach was necessary because assuming a
common constant mean across runs and sites was untenable as between-run, within-site
Pearson correlation coefficients were as low as 0.23 (median 0.39, maximum 0.73). Between
run correlations of mean LINE-1 were 0.6 for each of the three time points. We allowed a
separate set of 6 additional means for the 48 subjects for whom we measured LINE-1 at only
three sites. We used this approach because we observed differences between the samples
from these 48 subjects and the other subjects. We fit a random intercept and a general
covariance structure allowing different variances for each site and different correlations
between sites within run, and different correlations between and within site across runs. We
used the predicted random intercepts (the empirical Bayes’ estimates) as the underlying
LINE-1 methylation level for the analysis.
We examined LINE-1 as a continuous variable as well as in quartiles. For cord blood
LINE-1 we used sex-specific quartiles because males had higher levels. We ran unadjusted
and multivariable adjusted linear regression models to analyze differences in gestation
length, and logistic models for odds of preterm birth (<37 v. ≥37 weeks gestation). We
adjusted multivariable models for maternal age, race/ethnicity, pre-pregnancy BMI,
education, smoking during pregnancy, and fetal sex. To explore possible effect modification
by sex on the relationship between cord blood LINE-1 and gestational age we introduced
infant sex interaction terms to multivariable regression models. We also ran stratified
logistic multivariable regression models to determine whether the relationship between
preterm and LINE-1 differed by spontaneous vs. medically-indicated deliveries. We
performed all analyses using SAS version 9.2 (SAS Institute, Cary, NC).
RESULTS
Mean (SD) LINE-1 %5mC were 84.3 (0.6), 84.5 (0.7) and 84.6 (0.7) in first trimester,
second trimester and cord blood, respectively. Correlations among the 3 time points were
very low; (Pearson r=0.02 for first and second trimester LINE-1, 0.01 for second trimester
and cord LINE-1, and −0.04 for first trimester and cord). Women who were white,
multiparous, or married/cohabitating had slightly higher 1st trimester LINE-1 than their
counterparts (supplementary Table S1). Second trimester LINE-1 did not vary by covariates.
Cord blood LINE-1 was higher among male vs. female infants (84.8 vs. 84.4 P <0.001).
Mean (SD) gestational ages were 39.5 (1.7), 39.5 (1.7), and 39.7 (1.5) weeks among infants
included in first trimester, second trimester and cord blood analyses respectively. The
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percent of preterm infants (born <37 weeks’ gestation) was 6.3, 6.6 and 4.9 in the first
trimester, second trimester and cord LINE-1 analyses, respectively (Table 1).
Maternal blood LINE-1
First trimester LINE-1 was positively associated with gestational age in unadjusted and
adjusted models. Analysis of LINE-1 as a continuous variable revealed that each %5mC
increase in LINE-1 predicted 0.20 (95% CI 0.01, 0.39) weeks longer gestation. Covariate
adjustment did not change this estimate. Analyzing LINE-1 in quartiles, we found that
mothers with the highest versus the lowest quartile of first trimester LINE-1 predicted longer
gestations by an average of 0.45 weeks (95% CI 0.12, 0.78) (Fig.1). They also had
substantially lower odds of preterm birth (OR 0.40, 95% CI 0.17, 0.93) (Table 3). Covariate
adjustment did not materially alter this estimate. The odds ratios of preterm delivery
associated with the lowest (vs. highest) quartile of LINE-1 did not differ by spontaneous
(0.41, 95% CI 0.12, 1.34) and medically-indicated (0.35, 95% CI 0.10, 1.29) deliveries.
We did not detect any association between continuous second trimester LINE-1 and
gestational age (−0.05 weeks, 95% CI −0.32, 0.22), or quartiles of second trimester LINE-1
and gestational age (Table 2). Nor did we detect associations between second trimester
LINE-1 %5mC and preterm birth (OR for highest vs. lowest quartile 1.16, 95% CI 0.56,
2.40) (Table 3).
Cord blood LINE-1
Cord blood LINE-1 was inversely associated with gestational age (Table 4). For each %5mC
increase in cord blood LINE-1, gestational age was 0.19 weeks shorter (95% CI 0.01, 0.38)
in unadjusted models and the results did not change appreciably with adjustment for
covariates (0.18 weeks shorter, 95% CI −0.03, 0.38). Infants with the highest quartile of
cord blood LINE-1 were born 0.45 weeks (95% CI 0.08, 0.83) earlier than infants with the
lowest quartile of LINE-1 (Table 2). Cord blood LINE-1 was inversely associated with
preterm delivery. Infants in the highest sex-specific quartile of LINE-1 vs. the lowest
quartile had higher odds of having been born preterm (OR 3.87, 95% CI 1.05, 14.2).
Covariate adjustment only strengthened this association (OR 4.55, 95% CI 1.18, 17.5)
(Table 3). We found no differences in associations with mean gestational age (interaction p
= 0.97) or preterm birth (p = 0.84) according to infant sex.
DISCUSSION
In this cohort study, higher LINE-1 DNA methylation of maternal peripheral blood
leukocytes during the first trimester predicted longer gestation and decreased odds of
delivering preterm, as hypothesized. Conversely, we found cord blood LINE-1 DNA
methylation to be inversely correlated with the length of gestation. These associations
persisted after adjustment for many known risk factors for preterm birth. We observed
similar associations of 1st trimester LINE-1 with preterm birth irrespective of whether the
birth was spontaneous or medically induced. Medically indicated preterm birth may occur
when a fetus has been showing signs of distress or poor growth, or if the mother has
developed preeclampsia or other illness prompting delivery. Preeclampsia, characterized by
hypertension and proteinuria, accounts for approximately 20% of extremely preterm (<28
weeks’ gestation) deliveries.39 A broader category of ischemic placental disease is
responsible for over half of medically indicated preterm deliveries.40 Higher LINE-1 could
be a marker of less ischemic placental disease or preeclampsia. We previously showed that
higher LINE-1 expression is associated with lower risk of ischemic heart disease in non-
pregnant adults.41 Since preeclampsia may have roots early in placental development
secondary to implantation abnormalities, poor perfusion and subsequent endothelial
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damage,42 first trimester LINE-1 may be hypomethylated in preeclampsia as it is in
ischemic heart disease. Mean LINE-1 was lower in the first trimester among women who
developed preeclampsia (84.1 %5mC) compared to women who did not (84.3 %5mC)
(P=0.15). Preliminary analysis suggests a relationship between increasing first trimester
LINE-1 and decreased multivariable-adjusted odds of subsequent preeclampsia (OR 0.65,
95% CI 0.35, 1.19), but wide confidence intervals prevent conclusions about this
association. Further work should be done to evaluate potential associations between
maternal DNA methylation early in pregnancy and the development of preeclampsia.
Plausible mechanisms also support associations with spontaneous preterm birth, which can
result from preterm premature rupture of membranes secondary to cervical insufficiency, or
from preterm labor resulting from infection, uterine stretch from uterine fibroids, or trauma.
Inflammation is the hallmark of spontaneous preterm labor.43 In a nested case-control study
within Project Viva, we have shown that women with higher early pregnancy serum C-
reactive protein had higher odds of preterm delivery.44 We have also demonstrated LINE-1
hypomethylation to be associated with elevation vascular cell adhesion molecule-1
(VCAM-1).45 Furthermore, interleukin-6 can induce LINE-1 hypomethylation in oral cancer
cells studied in vitro.46 Others have proposed that LINE-1 hypomethylation itself could
contribute to inflammation and the development of autoimmune disease through triggering
the innate immunity pathway.47 LINE-1 hypomethylation may affect cellular function
through encouraging transcription of sequences activated during conditions of cellular stress
or inflammation.18, 19, 21
The lack of an association between second trimester LINE-1 methylation and preterm birth
remains somewhat puzzling, given the inverse association of first trimester LINE-1 with
odds of preterm birth. We speculate that LINE-1 status during the first trimester may reflect
the inflammatory state of the mother closer to the timing of implantation, the success of
which appears to be a key step for avoiding for pre-eclampsia and placental insufficiency
more broadly.48 Furthermore, the low correlation between 1st and 2nd trimester LINE-1
suggests that LINE-1 at these time points reflect different processes (Pearson r= 0.02).
In contrast to our findings with 1st trimester LINE-1, we found that infants with higher cord
blood LINE-1 had shorter gestations and higher odds of preterm birth. The cross-sectional
nature of these observations prevents conclusions about causality. While Tabano et al. found
that adult peripheral blood leukocytes had higher LINE-1 methylation (67.3%) than
umbilical cord blood (60.1%), most studies of adults32 and across the lifespan49 suggest that
global methylation decreases with age. We hypothesize that LINE-1 may become less
methylated as cells divide and thus decreases with age in fetal life as it does in adult life.
Furthermore, there are both maternal and fetal contributions to preterm birth. For example,
infants with multiple congenital anomalies are more likely to be born preterm regardless of
maternal health state.50 Thus, if indeed there is a causal relationship between DNA
methylation and preterm birth, it is possible that the impacts on the length of gestation of
maternal and fetal DNA methylation differ from one another.
A recent study comparing the global DNA methylation of placentas from preeclamptic
pregnancies and normotensive pregnancies revealed that methylation levels were higher in
preeclamptic placentas.51 While initially this may seem counter to our findings, another
study suggests discordance between placental and fetal tissue methylation with placental
tissue being relatively hypomethylated compared to the fetus.49 Tabano et al also found that
the placenta (n=46) displayed relative hypomethylation of LINE-1 methylation (41.8%,
range 34.0–52.3) compared to umbilical cord blood samples (n=10) (60.1%, range 57.5–
77.7).52 Despite using the same technique,53 we found our mean cord blood methylation
value of 84.6%5mC (range 71.5–86.5) is much higher. It is possible that simply by chance,
Burris et al. Page 6
J Dev Orig Health Dis. Author manuscript; available in PMC 2012 June 18.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
their small sample size obtained estimates on the lower end of what is expected. However, it
also highlights possible lack of comparability of DNA methylation values across studies.
Our findings should be considered in the context of inherent limitations. First, DNA
methylation of peripheral blood leukocytes may or may not reflect the methylation of the
tissues responsible for the conditions leading to preterm birth. Tissues such as the
myometrium may be more appropriate for DNA methylation studies of preterm labor risk.
Second, methylation of different leukocyte subtypes varies and we did not have the ability to
adjust for the leukocyte differential, although adjustment has not affected the results of other
cohort studies using LINE-1 methylation as an exposure.21, 45 Third, DNA methylation is
one of several epigenetic mechanisms that work in conjunction with one another to regulate
gene expression, and further work should be done to understand how histone modifications
or other mechanisms may affect the risk of preterm birth. Fourth, gene-specific or genome-
wide DNA methylation analyses may provide more insight into mechanisms underlying the
processes prompting preterm birth, and while such technologies exist, they continue to be
costly for cohort studies with large sample sizes. Fifth, the relatively high socio-economic
status of our cohort may limit the generalizability of our findings, but our findings should be
internally valid. Lastly, our preterm birth rate (6.5%) seems low compared to national
estimates of 12% overall, and 10–11% among singleton births in the last 2 decades.54
However, a more appropriate comparison for our singleton-only, Massachusetts-based
cohort may be the Massachusetts preterm birth rate of ~8%55 which includes multiples, who
are at higher risk of preterm birth, suggesting that our rate of 6.5% among singletons may be
representative of the region’s overall singleton rate.
In summary, we found that higher LINE-1 DNA methylation in maternal peripheral blood
DNA during the first trimester was associated with longer gestations and decreased odds of
preterm birth and that higher cord blood LINE-1 was associated with shorter gestations.
Whether LINE-1 methylation simply serves as a potential biomarker for preterm birth or
affects a woman’s risk of delivering preterm by altering gene expression and subsequent
cellular function awaits further study.
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Figure 1.
Multivariable-adjusted Associations of LINE-1 DNA methylation with Gestational Age at
Birth, Project Viva
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Table 1
Characteristics of Project Viva participants by blood sample in which LINE-1 was analyzed
1st Trimester Blood (n = 914) 2nd Trimester Blood (n = 922) Cord Blood (n = 557)
n (%)
Maternal age (years)
 15 – < 25 72 (7.9) 57 (6.2) 52 (9.3)
 25 – < 30 180 (19.7) 189 (20.5) 114 (20.5)
 30 – < 35 370 (40.5) 390 (42.3) 231 (41.5)
 35 – < 45 292 (31.9) 286 (31.0) 160 (28.7)
Race/ethnicity
 White 683 (74.9) 703 (76.5) 407 (73.2)
 Black 97 (10.6) 97 (10.6) 58 (10.4)
 Hispanic 62 (6.8) 50 (5.4) 43 (7.7)
 Other 70 (7.7) 69 (7.5) 48 (8.6)
Prepregnancy BMI (kg/m2)
 < 25 569 (62.5) 590 (64.2) 349 (62.9)
 25 – < 30 209 (22.9) 204 (22.2) 124 (22.3)
 ≥ 30 133 (14.6) 125 (13.6) 82 (14.8)
Education
 Less than college graduate 273 (29.9) 266 (28.9) 175 (31.5)
 College graduate 639 (70.1) 653 (71.1) 381 (68.5)
Smoking during pregnancy
 Never 595 (67.0) 620 (69.0) 373 (69.5)
 Former 192 (21.6) 190 (21.1) 111 (20.7)
 During pregnancy 101 (11.4) 89 (9.9) 53 (9.9)
Infant sex
 Male 481 (52.6) 470 (51.0) 294 (52.8)
 Female 433 (47.4) 452 (49.0) 263 (47.2)
Gestational age at delivery (weeks)
 < 34 15 (1.6) 12 (1.3) 6 (1.1)
 34 – <37 43 (4.7) 49 (5.3) 21 (3.8)
 ≥ 37 856 (93.7) 861 (93.4) 530 (95.2)
Values may not add up to total n because of missing data.
LINE-1, long interspersed nuclear element 1; %5mC, %5-methylated cytosines, BMI, body mass index
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Table 3
Odds of Preterm Birth by Quartile of LINE-1 DNA Methylation among 1160a Participants Enrolled in Project
Viva
Preterm Cases Unadjusted Adjustedb
n (%) OR (95% CI)
First Trimester
 1st quartile 19 (8.3) 1.0 (reference) 1.0 (reference)
 2nd quartile 17 (7.4) 0.88 (0.45, 1.74) 0.91 (0.45, 1.81)
 3rd quartile 14 (6.1) 0.72 (0.35, 1.47) 0.72 (0.35, 1.49)
 4th quartile 8 (3.5) 0.40 (0.17, 0.93) 0.40 (0.17, 0.94)
Second Trimester
 1st quartile 15 (6.5) 1.0 (reference) 1.0 (reference)
 2nd quartile 12 (5.2) 0.79 (0.36, 1.72) 0.79 (0.36, 1.75)
 3rd quartile 17 (7.4) 1.14 (0.55, 2.34) 1.14 (0.55, 2.37)
 4th quartile 17 (7.4) 1.14 (0.56, 2.35) 1.16 (0.56, 2.40)
Cord Blood (sex-specific quartiles)
 1st quartile 3 (2.2) 1.0 (reference) 1.0 (reference)
 2nd quartile 6 (4.3) 2.01 (0.49, 8.22) 2.14 (0.50, 9.08)
 3rd quartile 7 (5.0) 2.37 (0.60, 9.35) 2.29 (0.55, 9.48)
 4th quartile 11 (7.9) 3.87 (1.05, 14.2) 4.55 (1.18, 17.5)
a
First trimester n=914 (unadjusted) & n=884 (adjusted); second trimester n=922 (unadjusted) & n= 893 (adjusted); cord blood n=557 (unadjusted)
& n= 534 (adjusted) because of missing data.
bAdjusted for maternal age, BMI, race/ethnicity, education, smoking and infant sex in multivariable logistic regression models
LINE-1, long interspersed nuclear element-1, %5mC, %5-methylated cytosines
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